ENTEROBIASIS

ENTEROBIASIS was reported 149 times

These drug classes are most commonly taken by patients reporting ENTEROBIASIS:

# Drug Count
0 Interleukin-4 Receptor alpha Antagonist [EPC] 40
1 Corticosteroid [EPC] 33
2 Fluoroquinolone Antibacterial [EPC] 21
3 Anti-IgE [EPC] 16
4 Tumor Necrosis Factor Blocker [EPC] 12
5 Vitamin C [EPC] 9
6 Serotonin-3 Receptor Antagonist [EPC] 7
7 Folate Analog Metabolic Inhibitor [EPC] 6
8 Nonsteroidal Anti-inflammatory Drug [EPC] 6
9 Vitamin B12 [EPC] 6
10 Vitamin D [EPC] 6
11 Aminosalicylate [EPC] 5
12 Dihydropyridine Calcium Channel Blocker [EPC] 5
13 Nitroimidazole Antimicrobial [EPC] 5
14 Osmotic Laxative [EPC] 5
15 Proton Pump Inhibitor [EPC] 5
16 Provitamin D2 Compound [EPC] 5
17 Benzodiazepine [EPC] 4
18 Catecholamine [EPC] 4
19 Human Immunoglobulin G [EPC] 4
20 Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] 4
21 alpha-Adrenergic Agonist [EPC] 4
22 beta-Adrenergic Agonist [EPC] 4
23 Amide Local Anesthetic [EPC] 3
24 Anthelmintic [EPC] 3
25 Antiarrhythmic [EPC] 3
26 Interleukin-5 Antagonist [EPC] 3
27 Nonergot Dopamine Agonist [EPC] 3
28 Platinum-based Drug [EPC] 3
29 Vascular Endothelial Growth Factor Inhibitor [EPC] 3
30 Atypical Antipsychotic [EPC] 2
31 Ester Local Anesthetic [EPC] 2
32 Estrogen [EPC] 2
33 Glucosylceramide Synthase Inhibitor [EPC] 2
34 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2
35 Integrin Receptor Antagonist [EPC] 2
36 Interleukin-17A Antagonist [EPC] 2
37 Interleukin-6 Receptor Antagonist [EPC] 2
38 Non-Standardized Chemical Allergen [EPC] 2
39 Nucleoside Metabolic Inhibitor [EPC] 2
40 Platelet Aggregation Inhibitor [EPC] 2
41 Polyene Antifungal [EPC] 2
42 Potassium Salt [EPC] 2
43 Aminoglycoside Antibacterial [EPC] 1
44 Anti-epileptic Agent [EPC] 1
45 Anticholinergic [EPC] 1
46 Antisense Oligonucleotide [EPC] 1
47 Aromatic Amino Acid [EPC] 1
48 Azole Antifungal [EPC] 1
49 Barbiturate [EPC] 1
50 Central Nervous System Stimulant [EPC] 1
51 Cholinergic Muscarinic Antagonist [EPC] 1
52 Complement Inhibitor [EPC] 1
53 Dietary Cholesterol Absorption Inhibitor [EPC] 1
54 Enzyme Stabilizer [EPC] 1
55 Expectorant [EPC] 1
56 Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] 1
57 Histamine-1 Receptor Antagonist [EPC] 1
58 Histamine-2 Receptor Antagonist [EPC] 1
59 Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] 1
60 Insulin Analog [EPC] 1
61 Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] 1
62 Interferon alpha [EPC] 1
63 Interleukin-13 Antagonist [EPC] 1
64 Iron Chelator [EPC] 1
65 Kinase Inhibitor [EPC] 1
66 Lipid-based Polyene Antifungal [EPC] 1
67 Loop Diuretic [EPC] 1
68 Methylxanthine [EPC] 1
69 Microtubule Inhibitor [EPC] 1
70 Mood Stabilizer [EPC] 1
71 Non-narcotic Antitussive [EPC] 1
72 Nucleoside Analog Antiviral [EPC] 1
73 Phosphodiesterase 4 Inhibitor [EPC] 1
74 Retinoid [EPC] 1
75 Survival Motor Neuron-2-directed RNA Interaction [EPC] 1
76 Sympathomimetic-like Agent [EPC] 1
77 alpha-Adrenergic Blocker [EPC] 1
78 beta-Adrenergic Blocker [EPC] 1
79 beta3-Adrenergic Agonist [EPC] 1
80 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1